This template combines adaptations of diversion control strategies for OTPs described in the Federal Guidelines for Opioid Treatment Programs and adherence monitoring approaches that address diversion in SAMHSA’s Sublingual and Transmucosal Buprenorphine for Opioid Use Disorder.
Section: Sample Protocols and Policies
Topic:
Medication Assisted Treatment (MAT)
Process Improvement
Substance/Stimulant/Opiod Use Disorder
Process Improvement
Substance/Stimulant/Opiod Use Disorder
Setting:
Outpatient
Pharmacy
Pharmacy
Type: Best Practice/Policy/Guideline/Procedure